Genezen
Viral vector CDMO advancing gene and cell therapies from preclinical to commercial scale
Viral vector CDMO specializing in AAV, lentiviral, and retroviral manufacturing for gene and cell therapies, with cGMP facilities in Indiana and Massachusetts supporting preclinical through commercial-scale production. Headquartered in Fishers, United States.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Manufacturing (M)
Biologics / bioreactor infrastructure
- Bioreactor type
- Single-Use / DisposableStainless Steel
Regulatory clearances
Services
About this organization
Overview
Genezen is a gene and cell therapy CDMO founded in 2014, specializing in lentiviral, retroviral, and adeno-associated viral vector manufacturing. The company operates state-of-the-art facilities dedicated to advancing viral vector-based therapies from preclinical research through full-scale commercial manufacturing.
Facilities & Capacity
- Fishers, Indiana: 60,000 ft² cGMP-compliant facility serving as the primary viral vector manufacturing hub in the Indianapolis biotech corridor
- Lexington, Massachusetts: 86,000 ft² licensed viral vector manufacturing facility
- Over 10 years of cell and gene therapy (CGT) manufacturing experience
Services & Capabilities
Genezen provides comprehensive viral vector manufacturing solutions including:
- AAV (adeno-associated viral) vector manufacturing
- Lentiviral vector manufacturing
- Retroviral vector manufacturing
- Aseptic manufacturing across multiple viral vector modalities
- Development and manufacturing support from preclinical to GMP supply
- Flexible platforms to accelerate programs through all development stages
Quality & Compliance
The company emphasizes technical excellence and quality focus, with cGMP-compliant manufacturing capabilities supporting both research and commercial production.
Certifications
| Authority | Identifier | Source |
|---|---|---|
| FDA | cGMP compliant | View |
Locations
Headquarters & Manufacturing
Fishers · Indiana · United States
Viral Vector Manufacturing
Lexington · Massachusetts · United States
Recent news about Genezen
Genezen to Manufacture AAV Gene Therapy for SSADH Deficiency
Oct 16, 2026
Genezen to Manufacture AAV8 Gene Therapy for InterAct Therapeutics Breast Cancer Program
Oct 7, 2026
Genezen to Manufacture AAV9 Gene Therapy for N-of-1 ARCA2 Trial
Oct 1, 2026
4basebio Expands Genezen Partnership for GMP Synthetic DNA in Viral Vector Manufacturing
Aug 28, 2026
4basebio Expands Genezen Partnership for GMP Synthetic DNA in Viral Vector Manufacturing
Aug 27, 2026
Related companies
Similar profiles by shared services, modalities, and capabilities.
Andelyn Biosciences- Cell-Line Development
- Lentiviral Vector Manufacturing
Cell and Gene Therapy Catapult- Cell-Line Development
- Lentiviral Vector Manufacturing
Charles River Laboratories- Cell-Line Development
- Lentiviral Vector Manufacturing
Oxford Biomedica- Lentiviral Vector Manufacturing
- Viral Vector Manufacturing
AskBio- Viral Vector Manufacturing
- AAV Manufacturing
Aldevron- Cell-Line Development
- Lentiviral Vector Manufacturing
Minaris Advanced Therapies- Cell-Line Development
- Lentiviral Vector Manufacturing
BioInnovatise- Cell-Line Development
- Lentiviral Vector Manufacturing
Submit a verified review for this organization.
Markdown mirror: /companies/genezen.md